Roska unit centers around healthcare

Share this article:
Roska Direct Advertising has restructured into three distinct units, including a rebranded healthcare advertising arm.

Roska Direct Advertising will focus on the consumer and business-to-business markets, while the Roska Healthcare Advertising unit will be specific to healthcare advertising, and Roska Digital Advertising will focus on digital marketing.

Roska veteran Jay Bolling has been selected to lead Roska Healthcare Advertising as its president. Bolling recently told MM&M that the new unit would undergo a “subtle” introduction to the industry under its new brand identity. The group's results, however, will be anything but subdued, he explained.

“What we are trying to do with Roska Healthcare Advertising is focus on a message that will be very similar to the overall message of Roska,” he said. 

In the past, the Roska healthcare unit has worked with clients including Pfizer, AstraZeneca, GlaxoSmithKline and Bristol-Myers Squibb.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...